Table of Contents

2019-2024 Global Diagnostic Radiopharmaceuticals Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Diagnostic Radiopharmaceuticals Consumption 2014-2024
  • 2.1.2 Diagnostic Radiopharmaceuticals Consumption CAGR by Region
• 2.2 Diagnostic Radiopharmaceuticals Segment by Type
  • 2.2.1 Tc-99m
  • 2.2.2 F-18
  • 2.2.3 Other
• 2.3 Diagnostic Radiopharmaceuticals Consumption by Type
  • 2.3.1 Global Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Type (2014-2019)
• 2.4 Diagnostic Radiopharmaceuticals Segment by Application
  • 2.4.1 Oncology
  • 2.4.2 Cardiology
  • 2.4.3 Other
• 2.5 Diagnostic Radiopharmaceuticals Consumption by Application
  • 2.5.1 Global Diagnostic Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Diagnostic Radiopharmaceuticals Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Diagnostic Radiopharmaceuticals Sale Price by Application (2014-2019)

3 Global Diagnostic Radiopharmaceuticals by Players

• 3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Players
  • 3.1.1 Global Diagnostic Radiopharmaceuticals Sales by Players (2017-2019)
  • 3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Players (2017-2019)
• 3.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Players
  • 3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Players (2017-2019)
  • 3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Players (2017-2019)
• 3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Players
• 3.4 Global Diagnostic Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Diagnostic Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Diagnostic Radiopharmaceuticals Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Diagnostic Radiopharmaceuticals by Regions

• 4.1 Diagnostic Radiopharmaceuticals by Regions
  • 4.1.1 Global Diagnostic Radiopharmaceuticals Consumption by Regions
  • 4.1.2 Global Diagnostic Radiopharmaceuticals Value by Regions
• 4.2 Americas Diagnostic Radiopharmaceuticals Consumption Growth
• 4.3 APAC Diagnostic Radiopharmaceuticals Consumption Growth
• 4.4 Europe Diagnostic Radiopharmaceuticals Consumption Growth
• 4.5 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Growth

5 Americas

• 5.1 Americas Diagnostic Radiopharmaceuticals Consumption by Countries
  • 5.1.1 Americas Diagnostic Radiopharmaceuticals Consumption by Countries (2014-2019)
  • 5.1.2 Americas Diagnostic Radiopharmaceuticals Value by Countries (2014-2019)
• 5.2 Americas Diagnostic Radiopharmaceuticals Consumption by Type
• 5.3 Americas Diagnostic Radiopharmaceuticals Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Diagnostic Radiopharmaceuticals Consumption by Countries
  • 6.1.1 APAC Diagnostic Radiopharmaceuticals Consumption by Countries (2014-2019)
  • 6.1.2 APAC Diagnostic Radiopharmaceuticals Value by Countries (2014-2019)
• 6.2 APAC Diagnostic Radiopharmaceuticals Consumption by Type
• 6.3 APAC Diagnostic Radiopharmaceuticals Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Diagnostic Radiopharmaceuticals by Countries
  • 7.1.1 Europe Diagnostic Radiopharmaceuticals Consumption by Countries (2014-2019)
  • 7.1.2 Europe Diagnostic Radiopharmaceuticals Value by Countries (2014-2019)
• 7.2 Europe Diagnostic Radiopharmaceuticals Consumption by Type
• 7.3 Europe Diagnostic Radiopharmaceuticals Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Diagnostic Radiopharmaceuticals by Countries
  • 8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals Value by Countries (2014-2019)
• 8.2 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Type
• 8.3 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Diagnostic Radiopharmaceuticals Distributors
• 10.3 Diagnostic Radiopharmaceuticals Customer

11 Global Diagnostic Radiopharmaceuticals Market Forecast

• 11.1 Global Diagnostic Radiopharmaceuticals Consumption Forecast (2019-2024)
• 11.2 Global Diagnostic Radiopharmaceuticals Forecast by Regions
  • 11.2.1 Global Diagnostic Radiopharmaceuticals Forecast by Regions (2019-2024)
  • 11.2.2 Global Diagnostic Radiopharmaceuticals Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Diagnostic Radiopharmaceuticals Forecast by Type
• 11.8 Global Diagnostic Radiopharmaceuticals Forecast by Application

12 Key Players Analysis

• 12.1 Bracco Imaging
  • 12.1.1 Company Details
  • 12.1.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.1.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bracco Imaging News
• 12.2 Bayer
  • 12.2.1 Company Details
  • 12.2.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.2.3 Bayer Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Bayer News
• 12.3 Curium Pharmaceuticals
  • 12.3.1 Company Details
  • 12.3.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.3.3 Curium Pharmaceuticals Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Curium Pharmaceuticals News
• 12.4 Nordion
  • 12.4.1 Company Details
  • 12.4.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.4.3 Nordion Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Nordion News
• 12.5 Triad Isotopes
  • 12.5.1 Company Details
  • 12.5.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.5.3 Triad Isotopes Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Triad Isotopes News
• 12.6 Lantheus
  • 12.6.1 Company Details
  • 12.6.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.6.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Lantheus News
• 12.7 GE Healthcare
  • 12.7.1 Company Details
  • 12.7.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.7.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 GE Healthcare News
• 12.8 China Isotope & Radiation
  • 12.8.1 Company Details
  • 12.8.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 China Isotope & Radiation News
• 12.9 Jubilant Pharma
  • 12.9.1 Company Details
  • 12.9.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.9.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Jubilant Pharma News
• 12.10 Eli Lilly
  • 12.10.1 Company Details
  • 12.10.2 Diagnostic Radiopharmaceuticals Product Offered
  • 12.10.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Eli Lilly News
• 12.11 Novartis
• 12.12 SIEMENS
• 12.13 Dongcheng
• 12.14 Navidea

13 Research Findings and Conclusion

Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis

According to this study, over the next five years the Diagnostic Radiopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diagnostic Radiopharmaceuticals business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

This study considers the Diagnostic Radiopharmaceuticals value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tc-99m
F-18
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Diagnostic Radiopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Diagnostic Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Diagnostic Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diagnostic Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diagnostic Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.